Skip Navigation

Natalyn N Hawk, MD, PhD

Associate Professor of Hematology & Oncology
Emory School of Medicine

Dr. Hawk obtained her MD and PhD from Brown University in Providence, Rhode Island, during which she conducted her PhD research on protein-protein interactions in chronic myeloid leukemia as a visiting scientist at M.D. Anderson Cancer Center in Houston, Texas. She completed residency training in internal medicine at Johns Hopkins Bayview Medical Center in Baltimore, MD.

She completed a one year research fellowship at Emory University while conducting pre-clinical research on the effects of combined inhibition of  mTOR and EGF receptor on the growth of non small cell lung cancer cells.  She subsequently completed fellowship training in hematology and medical oncology at Emory University in 2010.

Full Clinical Bio >>

Research Interests

Dr. Hawk has a broad variety of clinical and translational research interests. As a physician seeing patients with either gastrointestinal or connective tissue malignancies, she has a strong interest in clinical trial development. As a member of the GI oncology working group, she is designing an early phase protocol utilizing multi-disciplinary approaches to the neoadjuvant treatment of pancreatic cancer. As a separate project, she is investigating the impact of age on the outcome of patients with advanced colon cancer.

As a member of the Sarcoma working group, Dr. Hawk is involved in opening trials for patients with advanced soft tissue sarcomas or advanced, recurrent or refractory gastrointestinal stromal tumors (GIST).

Publications

View publications on PubMed